Upside | ||||||
|---|---|---|---|---|---|---|
| JNJ | 22.48% | aa.aa | 152.41 | +0.26% | 821,947 | |
| LLY | 22.46% | aa.aa | 775.45 | -2.47% | 157,817 | |
| RPRX | 4.83% | aa.aa | 35.87 | +1.70% | 749,505 | |
| MRK | 4.55% | aa.aa | 79.10 | +0.34% | 317,719 | |
| PFE | 4.54% | aa.aa | 24.19 | -0.21% | 1,042,410 | |
| VTRS | 4.54% | aa.aa | 9.01 | -1.21% | 2,841,957 | |
| ZTS | 4.33% | aa.aa | 156.17 | +0.24% | 153,426 | |
| BMY | 4.27% | aa.aa | 46.35 | -0.64% | 508,793 | |
| CORT | 3.50% | aa.aa | 73.22 | -1.49% | 263,032 | |
| ELAN | 3.42% | aa.aa | 14.29 | -0.07% | 1,384,121 |
iShares Trust - iShares U.S. Pharmaceuticals ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the Dow Jones U.S. Select Pharmaceuticals Index, by using representative sampling technique. iShares Trust - iShares U.S. Pharmaceuticals ETF was formed on May 1, 2006 and is domiciled in the United States.